Akkermansia muciniphila AKM Lab-01

Akkermansia muciniphila · Moon (Guangzhou) Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Akkermansia muciniphila AKM Lab-01, covering 2025-12-30 to 2025-12-30. Get the full timeline:

Most recent: Clinical Trial Update: An Efficacy and Safety Study of Akkermansia Muciniphila AKM Lab-01 in Hypercholesterolaemia [NA]